Patient disposition (ITT population: total N = 35)
| . | No. (%) . |
|---|---|
| Received study drug | 34 (97.1) |
| Completed initial treatment phase | 25 (71.4) |
| Received re-treatment | 8 (22.9) |
| Completed follow-up period | 16 (45.7) |
| Completed treatment | 6 (17) |
| Reasons for discontinuation | |
| AE | 1 (2.9) |
| Disease progression | 20 (57.1) |
| DLT | 2 (5.7) |
| Investigator's decision | 2 (5.7) |
| Patient's decision | 2 (5.7) |
| Other | 2 (5.7) |
| . | No. (%) . |
|---|---|
| Received study drug | 34 (97.1) |
| Completed initial treatment phase | 25 (71.4) |
| Received re-treatment | 8 (22.9) |
| Completed follow-up period | 16 (45.7) |
| Completed treatment | 6 (17) |
| Reasons for discontinuation | |
| AE | 1 (2.9) |
| Disease progression | 20 (57.1) |
| DLT | 2 (5.7) |
| Investigator's decision | 2 (5.7) |
| Patient's decision | 2 (5.7) |
| Other | 2 (5.7) |
ITT indicates intent to treat.